Cytokines in dementia of the Alzheimer's type (DAT): relevance to research and treatment (Q40860080)

24 September 2017

1 reference

title

Cytokines in dementia of the Alzheimer's type (DAT): relevance to research and treatment (English)

1 reference

24 September 2017

0 references

P. Malek-Ahmadi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9579327

21 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9579327

21 December 2024

publication date

1 May 1998

1 reference

24 September 2017

May 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9579327

full work available at URL

21 December 2024

https://api.elsevier.com/content/article/PII:S0149763497000274?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)00027-4

https://api.elsevier.com/content/article/PII:S0149763497000274?httpAccept=text/plain

21 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)00027-4

Neuroscience & Biobehavioral Reviews

21 December 2024

published in

1 reference

24 September 2017

volume

22

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

389-394

1 reference

Cytokines: From clone to clinic

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Cytokines in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Focusing on IL-1-promotion of beta-amyloid precursor protein synthesis as an early event in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Interleukin-1 stimulates the beta-amyloid precursor protein promoter

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Altered expression of transforming growth factor-beta in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells Potential significance for the processing of Alzheimer β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Tau protein and the neurofibrillary pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

The association between head trauma and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Cytokines and neurokines: related ligands and related receptors

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Immunological dysfunction in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Neuropeptides: ACTH-peptides in dementia

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Immune system associated antigens expressed by cells of the human central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Neuropsychiatric aspects of cytokines research: an overview

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Relationship of interleukin-1β and β2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Immunoassays for detecting cytokines: What are they really measuring?

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Glial cytokines in Alzheimer's disease: Review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Synthesis of nitric oxide in CNS glial cells.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Cytokines and the nervous system II: Actions and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Alzheimer's disease: pathology to potential treatments?

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Physiological and pathophysiological roles of nitric oxide in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)50027-4

7 January 2021

Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice

series ordinal

8

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)00027-4

Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients

21 December 2024

series ordinal

32

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)00027-4

Differential Expression of TGF-β1, 2 and 3 Isotypes in Alzheimerʼs Disease: A Comparative Immunohistochemical Study with Cerebral Infarction, Aged Human and Mouse Control Brains

21 December 2024

series ordinal

47

1 reference

https://api.crossref.org/works/10.1016/S0149-7634(97)00027-4

21 December 2024

Identifiers

1 reference

24 September 2017

1 reference